Related Experiment Videos

Prostate cancer chemotherapy: emerging from the shadows

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

|March 2, 2005

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial).

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023

Orteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216).

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2022

Vorolanib (X-82), an oral anti-VEGFR/PDGFR/CSF1R tyrosine kinase inhibitor, with everolimus in solid tumors: results of a phase I study.

Investigational new drugs·2021

Management of Muscle-Invasive Bladder Cancer During a Pandemic: Impact of Treatment Delay on Survival Outcomes for Patients Treated With Definitive Concurrent Chemoradiotherapy.

Clinical genitourinary cancer·2020

Management of Clinical Stage I Germ Cell Tumors.

The Urologic clinics of North America·2019

Effectiveness of postoperative radiotherapy after radical cystectomy for locally advanced bladder cancer.

Cancer medicine·2019

See all related articles